In this section, your goal is to provide the FDA with information related to meeting minutes. After your Pre-IND meeting, the FDA will issue meeting minutes summarizing the content discussed, 30 days after the meeting. The purpose of this is to give you the opportunity to review what was discussed. If there are any aspects that you disagree with in the minutes, then you can request clarification or suggest changes (which the FDA may or may not agree with). It is important to note that responses to these minutes will have to be included in the IND submission, and the contents need to be addressed in the actual drug development period between Pre-IND and IND submission. You can find an example of the meeting minutes/summary linked here: MSD Pre-IND FDA meeting summary.
It is highly recommended that you also write your own meeting minutes and provide them to the FDA right after the meeting, as this is helpful to the Agency and can also further accelerate the process. It is also recommended to log your interaction minutes and develop a game plan for how you plan to address/modify plans as needed, or to prepare for the next interaction with the FDA on topics as warranted.